Sutura Therapeutics is a biopharmaceutical company at the forefront of developing next-generation biomolecular medicines. Through its innovative drug conjugate platform, Sutura is advancing the field of biomolecular medicine to address the unmet medical needs of patients with diseases which were previously considered undruggable.

Biomolecule-based medicines have unique biological properties and actions, which make them promising in treating diseases. However, the size and shape of biomolecules often limit their capacity to enter cells and reach their target, making them less effective. Sutura’s drug conjugates platform is designed to overcome these limitations and has the potential to address a broad range of indications.

Biotechnology

Life Sciences

Pharmaceutical

Sutura Therapeutics Ltd

Edwin Wagena

Steve Cox

The Research and Development team at Sutura Therapeutics Ltd focuses on the discovery and optimization of next-generation biomolecular medicines. This team works on developing innovative drug conjugates to overcome the limitations of traditional biomolecule-based medicines, ensuring they can effectively enter cells and reach their targets. Their efforts are crucial in advancing treatments for diseases that were previously considered undruggable.

Research and Development

About

Team members

Other teams at Sutura Therapeutics Ltd

Leadership Team